HLA class I alleles, one known and one newly identified, are linked to allopurinol-induced severe cutaneous adverse reactions ...

Activates innate and adaptive immune pathways, including increased antigen-experienced CD8 + T cells, activated CD4 + T cells, and Ki67 + NK cells. Induces immune-regulating chemokines CXCL9 and ...

SITC abstracts highlight updated immunogenicity results from the Phase 2 AMPLIFY-7P trial of ELI-002 7P and preclinical data on the use of ...

A new HLA class I allele has been linked to a significantly increased risk for allopurinol-induced severe cutaneous adverse reactions.

Immune checkpoint blockade (CPB) — targeting checkpoint inhibitors such as programmed cell death protein 1 (PD1) to enhance the antitumour activity of CD8 + T cells — has revolutionized the treatment ...

Type 1 diabetes, celiac disease, and Hashimoto thyroiditis are all strongly associated with HLA class II genes, authors of an observational study that found links among the diseases.

Tevogen (TVGN) announced a clinical milestone in the evolution of its proprietary ExacTcell platform: completion of T cell target identification ...

Human leukocyte antigen B27 (HLA-B27) is a protein located on the surface of your white blood cells. An HLA-B27 test is a blood test that identifies HLA-B27 proteins. Human leukocyte antigens (HLAs) ...